Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women

Por Bekker, L.G., Li, S., Pathak, S., Tolley, E.E., Marzinke, M.A., Justman, J.E., Mgodi, N.M., Chirenje, M., Swaminathan, S., Adeyeye, A., Farrior, J., Hendrix, C.W., Piwowar-Manning, E., Richardson, P., Eshelman, S.H., Redinger, H., Williams, P., Sista, N.D.
Publicado no EClinicalMedicine (2020)